Skip to content
★ Sign in to follow
SF

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Stock: price and insider trades · China

复旦张江

CN·Mcap CN¥7.6BHealth Care

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.: what insiders have been doing

Every trade that managers of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. The previous disclosure was published on 10 December 2024.

Over the whole record (from 2021), the tally stands at no purchases and 17 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Insider Decl.
17
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€4M
17 ops. · all time

Who traded when

BuySale
张文伯1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 18,599 of 26,911 companies
38.8
score / 100
Value
36
Quality
41
FCF yld1.4%
Earn yld-2.1%
EV/EBITDA·
ROE-5.7%
Gross mgn90%
Net mgn-23%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥7.27
Analyst consensus
·
Income statement
RevenueCN¥685.8M
Gross profitCN¥616.5M90% margin
EBITDA-CN¥140.9M-21% margin
Net income-CN¥157.4M-18.9% margin
Valuation
P/Book3.5x
Beta0.06
Balance sheet & cash
Market capCN¥7.6B
Total debtCN¥14.7M
Free Cash FlowCN¥109M
Debt / Equity1%
Profitability & ownership
ROE-5.7%
ROA-3.4%
% insiders60.2%
% institutions0.3%
Last declaration on 10 December 2024
Declarations17 total
  • ▼
    核心技术人员Executives
    5M CNY10SSE
    550,000 shares100.0% of flowA股XSHGSSE:173000008342197100
  • ▼
    核心技术人员Executives
    625,800 CNY10SSE
    60,000 shares100.0% of flowA股XSHGSSE:173000006991510800
  • ▼
    核心技术人员Executives
    234,720 CNY4SSE
    24,000 shares19.9% of flowA股XSHGSSE:173000006812338180
  • ▼
    核心技术人员Executives
    465,120 CNY6SSE
    48,000 shares39.6% of flowA股XSHGSSE:173000006805712450
  • ▼
    核心技术人员Executives
    1M CNY10SSE
    100,000 shares100.0% of flowA股XSHGSSE:173000005652205570
  • ▼
    核心技术人员Executives
    439,500 CNY21SSE
    30,000 shares40.5% of flowA股XSHGSSE:173000005223704450
  • ▼
    董事,高级管理人员Executives
    1M CNY20SSE
    85,000 shares9.4% of flowA股XSHGSSE:173000005190207800
  • ▼
    董事,高级管理人员Executives
    2M CNY21SSE
    164,000 shares18.1% of flowA股XSHGSSE:173000005185998080
  • ▼
    董事,高级管理人员Executives
    7M CNY27SSE
    500,000 shares100.0% of flowA股XSHGSSE:173000005183738050
  • ▼
    董事,高级管理人员Executives
    3M CNY9SSE
    200,198 shares22.6% of flowA股XSHGSSE:173000005166919940
  • ▼
    董事,高级管理人员Executives
    715,100 CNY8SSE
    50,000 shares5.6% of flowA股XSHGSSE:173000005154497200
  • ▼
    董事,高级管理人员Executives
    484,299 CNY7SSE
    33,742 shares3.8% of flowA股XSHGSSE:173000005142943700
  • ▼
    董事,高级管理人员Executives
    588,520 CNY7SSE
    40,000 shares4.6% of flowA股XSHGSSE:173000005138676450
  • ▼
    董事,高级管理人员Executives
    2M CNY8SSE
    112,000 shares12.5% of flowA股XSHGSSE:173000005106015800
  • ▼
    董事,高级管理人员Executives
    915,525 CNY8SSE
    65,000 shares7.1% of flowA股XSHGSSE:173000005085873950
  • ▼
    董事,高级管理人员Executives
    771,705 CNY8SSE
    55,000 shares5.9% of flowA股XSHGSSE:173000005069895230
  • ▼
    董事,高级管理人员Executives
    1M CNY8SSE
    97,000 shares10.4% of flowA股XSHGSSE:173000005064075360

17 of 17 declarations

About Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Fudan Zhangjiang is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research and development of innovative drugs.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations